Menopause and Heart Health:
What Every Woman Should Know
After menopause, a woman's cardiovascular risk rises sharply. Understanding why — and what to do about it — is one of the most important health conversations women can have.
In brief: Cardiovascular disease is the leading cause of death in women over 60. The menopausal transition — and the loss of oestrogen's cardioprotective effects — is a key driver of this increased risk.[1] At Victoria Medical, Dr Xynopoulos offers a dedicated menopause cardiovascular risk assessment combining cardiology and gynaecology expertise.
How Menopause Affects the Heart
Before menopause, oestrogen provides significant cardiovascular protection — it promotes vasodilation, reduces LDL cholesterol, increases HDL cholesterol, and has anti-inflammatory effects on the arterial wall. After menopause, the loss of oestrogen reverses many of these protective effects. A 2022 review in Endocrine Connections found that the changing hormonal milieu at menopause predisposes women to visceral obesity, atherogenic dyslipidaemia, dysregulation in glucose homeostasis, and arterial hypertension — a constellation of risk factors that significantly accelerates cardiovascular disease progression.[1]
| Risk Factor | Mechanism |
|---|---|
| Oestrogen withdrawal | Loss of vasodilatory and anti-inflammatory effects of oestrogen on the endothelium |
| Atherogenic dyslipidaemia | LDL cholesterol rises, HDL falls, triglycerides increase after menopause |
| Visceral adiposity | Central fat redistribution increases insulin resistance and cardiovascular risk |
| Hypertension | Blood pressure rises significantly in the perimenopausal period |
| Endothelial dysfunction | Reduced nitric oxide production impairs vascular tone and flexibility |
| Early menopause (<45 years) | Independently associated with increased CVD risk — warrants HRT consideration |
HRT and Cardiovascular Risk: The Current Evidence
The relationship between HRT and cardiovascular risk has been extensively debated. A landmark 2024 Swedish nationwide study involving 919,614 women found that transdermal oestrogen combined with micronised progesterone was not associated with increased cardiovascular risk — and that tibolone was associated with a significantly increased risk (HR 1.52).[2] NICE NG23 recommends that HRT decisions should be individualised, taking into account the woman's cardiovascular risk profile, symptom burden, and personal preferences.[6]
From Our Practice — Dr George Xynopoulos
"As a cardiologist who works closely with our gynaecology team, I see the intersection of menopause and cardiovascular health regularly. Women often come to me with palpitations, breathlessness, or chest discomfort that they attribute to menopause — and sometimes they are right. But it is important to distinguish menopausal symptoms from genuine cardiac pathology. I always recommend a cardiovascular risk assessment at the time of menopause — blood pressure, lipids, glucose, and an ECG at minimum. It is an opportunity to reset the baseline and put preventive strategies in place."
Frequently Asked Questions
Does menopause cause heart disease?
Menopause does not directly cause heart disease, but the hormonal changes associated with menopause — particularly the loss of oestrogen — significantly increase cardiovascular risk factors. After menopause, women's cardiovascular risk approaches that of men of the same age. Early menopause (before age 45) is independently associated with increased CVD risk.
Does HRT protect the heart?
The evidence on HRT and cardiovascular protection is nuanced. A 2024 Swedish nationwide study found that transdermal oestrogen with micronised progesterone was not associated with increased cardiovascular risk, and may be cardioprotective when started within 10 years of menopause. Tibolone was associated with increased risk. NICE NG23 recommends that HRT decisions should be individualised.
What cardiovascular tests should women have at menopause?
Women entering menopause should have a comprehensive cardiovascular risk assessment including blood pressure measurement, fasting lipid profile (cholesterol), fasting glucose, BMI, and family history review. An ECG and echocardiogram may be recommended if symptoms are present. At Victoria Medical, we offer a dedicated menopause cardiovascular risk assessment.
Can lifestyle changes reduce cardiovascular risk at menopause?
Yes. Regular aerobic exercise, a Mediterranean-style diet, smoking cessation, and weight management are all evidence-based interventions that reduce cardiovascular risk at menopause. A 2019 Cochrane review found that lifestyle interventions significantly improved metabolic and cardiovascular risk markers in women with PCOS — similar principles apply to menopausal women.
Do I need a GP referral to see a cardiologist about menopause and heart health?
No. At Victoria Medical you can self-refer for a private cardiology or gynaecology consultation without a GP referral. Dr Xynopoulos has particular expertise in the intersection of cardiovascular risk and hormonal health.
References
- [1]Anagnostis P, Christou K, Artzouchaltzi AM, et al. Menopause-associated risk of cardiovascular disease. Endocr Connect. 2022;11(3):e210537. https://doi.org/10.1530/EC-21-0537
- [2]Johansson T, Vinogradova Y, Bhatt DL, et al. Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial. BMJ. 2024;385:e078784. https://doi.org/10.1136/bmj-2023-078784
- [3]Boardman HMP, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;3:CD002229. https://doi.org/10.1002/14651858.CD002229.pub4
- [4]Mehta LS, Beckie TM, DeVon HA, et al. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation. 2016;133(9):916–947. https://doi.org/10.1161/CIR.0000000000000351
- [5]Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20(1):47–63. https://doi.org/10.1016/0091-7435(91)90006-P
- [6]NICE. Menopause: diagnosis and management. NICE guideline NG23. 2015 (updated 2019). https://www.nice.org.uk/guidance/ng23
Dr George Xynopoulos
Consultant Physician & Cardiologist | GMC Registered | MRCP (UK)
Dr Xynopoulos is a Consultant Physician and Cardiologist at Victoria Medical, 170 Vauxhall Bridge Road, London.
View full profile →Menopause Cardiovascular Assessment
Combined cardiology and gynaecology expertise at Victoria Medical. No referral needed.
020 3146 9508